00000nam 2200000zi 4500 9.913119 CaOODSP 20221107182724 m o d f cr cn||||||||| 220707e20220714onc ob f000 0 eng d 9780660444543 (report) 9780660444550 (summary) CaOODSP eng rda CaOODSP n-cn--- HP5-139/1-2022E-PDF HP5-139/2-2022E-PDF Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age. Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, July 14, 2022. ©2022 1 online resource (27 pages) + summary (6 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Recommandations sur l'utilisation du vaccin Spikevax de Moderna contre la COVID-19 chez les enfants de 6 mois à 5 ans. At head of title: An Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI). Issued also in HTML format. Includes bibliographical references (pages 25-27). COVID-19 (Disease) Vaccination Canada. Vaccination of children Canada. Public Health Agency of Canada, issuing body. Recommandations sur l'utilisation du vaccin Spikevax de Moderna contre la COVID-19 chez les enfants de 6 mois à 5 ans. (CaOODSP)9.913120 PDF 678 KB https://publications.gc.ca/collections/collection_2022/aspc-phac/HP5-139-1-2022-eng.pdf (report) PDF 419 KB https://publications.gc.ca/collections/collection_2022/aspc-phac/HP5-139-2-2022-eng.pdf (summary) HTML N/A https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-moderna-spikevax-covid-19-vaccine-children-6-months-5-years.html (report) HTML N/A https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-moderna-spikevax-covid-19-vaccine-children-6-months-5-years/summary-july-14-2022.html (summary) 220315 (main report) 220313 (summary)